Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VON WILLEBRAND FACTOR Cause Product use issue? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product use issue have been filed in association with VON WILLEBRAND FACTOR. This represents 6.6% of all adverse event reports for VON WILLEBRAND FACTOR.

15
Reports of Product use issue with VON WILLEBRAND FACTOR
6.6%
of all VON WILLEBRAND FACTOR reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product use issue From VON WILLEBRAND FACTOR?

Of the 15 reports, 2 (13.3%) required hospitalization.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VON WILLEBRAND FACTOR. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does VON WILLEBRAND FACTOR Cause?

No adverse event (41) Haemorrhage (23) Epistaxis (14) Drug ineffective (13) Haemarthrosis (12) Off label use (12) Gastrointestinal haemorrhage (10) Product reconstitution quality issue (10) Product dose omission issue (9) Fall (8)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which VON WILLEBRAND FACTOR Alternatives Have Lower Product use issue Risk?

VON WILLEBRAND FACTOR vs VON WILLEBRAND FACTOR HUMAN VON WILLEBRAND FACTOR vs VONOPRAZAN VON WILLEBRAND FACTOR vs VONOPRAZAN FUMURATE VON WILLEBRAND FACTOR vs VORAPAXAR VON WILLEBRAND FACTOR vs VORASIDENIB

Related Pages

VON WILLEBRAND FACTOR Full Profile All Product use issue Reports All Drugs Causing Product use issue VON WILLEBRAND FACTOR Demographics